Is Pine Bark Extract Supplement Circulation Randomized Trial safe?

The current Migaku evidence database contains 1 reusable source document for Pine Bark Extract Supplement Circulation Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Results For all plant substances investigated, there are reports of anti-inflammatory or immunological effects in vitro and/or in animal models; however, the evidence for a clinically relevant benefit is very limited. [Keyßer G (2026); evidence level 2] - Conclusion The scientific analysis of a second series of herbal preparations has also shown that the confirmed value of phytotherapy for the field is limited; however, for the rheumatological practice a differentiated consideration is needed for the herbal preparations presented here. [Keyßer G (2026); evidence level 2] - Introduction Medicinal plants and their preparations are of great interest to many patients with rheumatic diseases. [Keyßer G (2026); evidence level 2] - In 2023 the German Society for Rheumatology and Clinical Immunology (DGRh) Committee for Complementary Medicine and Nutrition (KHE) began reviewing the scientific literature on selected phytotherapeutic agents and herbal preparations and examining their potential applications in rheumatology. [Keyßer G (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.